September 11, 2014
(Digital Journal) – Ryan Benton, a 28 year-old Duchenne’s muscular dystrophy patient from Wichita, Kansas, received his first umbilical cord tissue-derived mesenchymal stem cell treatment yesterday following US FDA approval of his doctor’s application for a single patient, investigational new … Read More
September 10, 2014
(Nature) – A Japanese patient with a debilitating eye disease is about to become the first person to be treated with induced pluripotent stem cells, which have generated enthusiastic expectations and earned their inventor a Nobel Prize. A health-ministry committee … Read More
September 9, 2014
(Phys.org) – Now, in a new study published today, Sept. 8, in the Proceedings of the National Academy of Sciences, a team of researchers from the University of Wisconsin-Madison has added a new wrinkle to the cell differentiation equation, showing … Read More
September 8, 2014
(Irish Examiner) – Human trials on the effectiveness of using adult stem cells in the fight against cornea transplant rejection could be under way within the next five years. Corneal eye disease is the fourth most common cause of blindness … Read More
September 5, 2014
(Phys.org) – A group of researchers from the Centre for Genomic Regulation in Barcelona have described the role of a protein that is crucial for cell reprogramming. The discovery also details the dynamics of this protein as well as its … Read More
September 5, 2014
(Phys.org) – Induced pluripotent stem cells (iPSCs)—adult cells reprogrammed back to an embryonic stem cell-like state—may hold the potential to cure damaged nerves, regrow limbs and organs, and perfectly model a patient’s particular disease. Yet through the reprogramming process, these … Read More
September 5, 2014
(Medscape) – Stem cell transplantation with melphalan is still the preferred treatment for younger patients with multiple myeloma, even in the era of new therapies for the disease, according to a phase 3 trial. The results were published in the September 4 … Read More
September 4, 2014
(Science Codex) – A team of researchers from Korea and Canada have found that transplantation of B10 cells (a stable immortalized human bone marrow derived –mesenchymal stem cell line; B10 hMSC) directly into the bladder wall of mice modeled with … Read More
September 2, 2014
(Phys.org) – For the development of new drugs it is crucial to work with stem cells, as these allow scientists to study the effects of new active pharmaceutical ingredients. But it has always been difficult to derive enough stem cells … Read More
September 1, 2014
(News-Medical) – A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells used to treat cancer patients. These findings could have implications that extend … Read More
September 1, 2014
(Medscape) – An intensive approach to autologous stem cells transplantation has allowed a return to normal function for patients with stiff person syndrome (SPS). Researchers at the Ottawa Blood and Marrow Transplant Program have so far performed transplants on 3 … Read More
August 29, 2014
(The Japan Times) – A Japanese team plans to launch a clinical study in which stem cells contained in umbilical cord blood will be administered to newborns with encephalopathy to prevent severe complications like brain paralysis from occurring. The Health, … Read More
August 28, 2014
(Fox News) – People with a rare disease called stiff person syndrome, or SPS, might benefit from a type of stem cell transplant that has been used to treat patients with leukemia and multiple sclerosis, researchers say. SPS is a … Read More
August 28, 2014
(The Guardian) – On the other side of the door, scientists in the Laboratory for Organogenesis and Neurogenesis are working on something that has fired the imagination of science fiction authors for many years. They are at the cutting edge … Read More
August 27, 2014
(Daily Mail) – Patients with chronic heart failure are to receive pioneering stem cell treatment in a new trial which could herald a cure for the biggest killer ‘in the industrial world’. Those taking part in the trial will get … Read More
August 22, 2014
(Eurekalert) – Mesenchymal stem cells (MSCs) are present in virtually every type of human tissue and may help in organ regeneration after injury. But the theory that MSCs are released from the bone marrow into the blood stream following organ … Read More
August 13, 2014
(FDA) – One of FDA’s primary missions is to make sure that the products we approve are safe and effective. There is tremendous interest in the development of regenerative medicine, including numerous proposed products that rely on stem cells. Stem … Read More
August 11, 2014
(News-Medical) – The study, led by Queen May University of London (QMUL) and published today in the journal Cell Reports, discovered how many stem cells exist within the human bowel and how they behave and evolve over time. It was … Read More
August 11, 2014
(The Guardian) – Stroke patients who took part in a small pilot study of a stem cell therapy have shown tentative signs of recovery six months after receiving the treatment. Doctors said the condition of all five patients had improved … Read More
August 8, 2014
(Medical News Today) – Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs … Read More
August 8, 2014
(Diabetes Insider) – An experimental research into the possible use of stem cell treatment to help prevent heart failure has now been halted due to several of the recipients of the therapy suffering from adverse effects. It is said that … Read More
August 7, 2014
(Forbes) – Shares of Cytori Therapeutics took a big bit hit today after the company disclosed in a press release that it had suspended enrollment in its ATHENA and ATHENA II trials. This kind of news is never a good sign, … Read More
August 5, 2014
(The Wall Street Journal) – Neuralstem, Inc. (NYSE MKT: CUR) announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig’s … Read More
August 5, 2014
(Medical Xpress) – Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have grafted neurons reprogrammed from skin cells into the brains of mice for the first time with long-term stability. Six months after implantation, … Read More
August 4, 2014
(Eurekalert) – In the cell, proteins similarly read through messages to distinguish what needs to be saved and what needs to be discarded. But, here, the process takes on a much more important role. More than just clutter, messages that … Read More
